The lack of EPO effect on IL-6 and IFN-γ transcripts in diluent-treated healthy mice supports the notion that the EPO-mediated effects in MM, are conferred via EPO-R expressing cells as direct and/or indirect pathways involving MM. The gene discussed is EPO; the disease is Miyoshi myopathy.